Breast Cancer

• CLINICAL_TRIALS research · 2026-03-13
  Clinical Trial Update: Plyometric Strength-Endurance Exercise in Breast Cancer [NA]

  A clinical trial update for plyometric strength-endurance exercise in breast cancer patients, with the study status listed as not yet recrui…

• CLINICAL_TRIALS research · 2026-03-13
  Clinical Trial Update: Study on Using TROP2-PET and 18F-FDG PET to Predict the Efficacy of Anti TROP2 ADC Treatment in Advanced Breast Cancer [Phase 2]

  Phase 2 clinical trial from Fudan University evaluating whether TROP2-PET and 18F-FDG PET imaging can predict response to an anti-TROP2 anti…

• CLINICAL_TRIALS research · 2026-03-13
  Clinical Trial Update: Camrelizumab Plus Risedronate and Chemotherapy for Triple-Negative Breast Cancer: An Exploratory Clinical Study on Mechanisms and Efficacy [Phase 2]

  A Phase 2 exploratory clinical study is evaluating camrelizumab plus risedronate and chemotherapy for triple-negative breast cancer, focusin…

• CLINICAL_TRIALS research · 2026-03-13
  Clinical Trial Update: Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Breast Cancer w/Liver Dominant Disease [Phase 2]

  A Phase 2 clinical trial is evaluating the safety and efficacy of delivering high-dose melphalan directly into the liver, followed by an app…

• CLINICAL_TRIALS research · 2026-03-13
  Clinical Trial Update: Pyrotinib Combined With Trastuzumab and Pertuzumab for Maintenance Therapy in HER2-Positive Advanced Breast Cancer

  This clinical trial investigates combining pyrotinib with trastuzumab and pertuzumab as maintenance therapy for HER2-positive advanced breas…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2026-03-13
  Clinical Trial Update: Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03) [Phase 2]

  A Phase 2 study evaluating patritumab deruxtecan in combination with pembrolizumab and other anticancer agents for high-risk early-stage tri…

• CLINICAL_TRIALS research · 2026-03-13
  Clinical Trial Update: Feasibility Study of CBCT for IGRT in Cancer Patients [NA]

  This is a feasibility study evaluating cone-beam CT imaging for image-guided radiotherapy (IGRT) in cancer patients. The trial is currently …

• CLINICAL_TRIALS research · 2026-03-13
  Clinical Trial Update: OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer [Phase 3]

  Phase 3 trial evaluating Palazestrant (OP-1250) versus standard of care for ER-positive, HER2-negative advanced/metastatic breast cancer is …

• CLINICAL_TRIALS research · 2026-03-13
  Clinical Trial Update: Impact of Sequential Chemotherapy on Young Patients Breast Cancer Treated Fertility

  The clinical trial update notes that the study evaluating the impact of sequential chemotherapy on fertility in young breast cancer patients…

• CLINICAL_TRIALS research · 2026-03-13
  Clinical Trial Update: Level I-II Axillary Irradiation in Breast Cancer With Sentinel-Node Macro-metastases [NA]

  A clinical trial evaluating Level I-II axillary irradiation in breast cancer patients with sentinel-node macro-metastases is currently recru…

• CLINICAL_TRIALS research · 2026-03-13
  Clinical Trial Update: Hypofractionated Regional Nodal Irradiation Clinical Trial for Women With Breast Cancer [NA]

  The document provides an update on a clinical trial evaluating hypofractionated regional nodal irradiation for women with breast cancer, wit…

• CLINICAL_TRIALS research · 2026-03-13
  Clinical Trial Update: A Study of Biological, Genetic, and Constitutional Factors and Non-invasive Monitoring to Assess Personal Cancer Risks

  This clinical trial investigates how biological, genetic, and constitutional factors, plus non-invasive monitoring, can help assess individu…

• CLINICAL_TRIALS research · 2026-03-13
  Clinical Trial Update: Survivorship Care Planning in Improving the Quality of Life in Breast Cancer Survivors [NA]

  This clinical trial assesses survivorship care planning to improve quality of life in breast cancer survivors and is currently active but no…

• CLINICAL_TRIALS research · 2026-03-13
  Clinical Trial Update: Real-life Evaluation of Endopredict® in Early HR+/HER2- Breast Cancer

  The entry reports a real-world clinical trial evaluating the Endopredict prognostic test in early HR-positive, HER2-negative breast cancer; …

• CLINICAL_TRIALS research · 2026-03-13
  Clinical Trial Update: Online Nutrition Education to Decrease the Side Effects of Chemotherapy in Patients With Breast Cancer [NA]

  A clinical trial update describing an online nutrition education program intended to reduce chemotherapy side effects in breast cancer patie…

• CLINICAL_TRIALS research · 2026-03-12
  Clinical Trial Update: Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors [Phase 1, Phase 2]

  A Phase 1/2 clinical trial evaluating the combination of AMXT 1501 and DFMO with standard therapies in patients with advanced solid tumors, …

• CLINICAL_TRIALS research · 2026-03-12
  Clinical Trial Update: The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) [Phase 1, Phase 2]

  PMV Pharmaceuticals is evaluating PC14586 in a Phase 1/2 trial for advanced solid tumors harboring the TP53 Y220C mutation. The study is cur…

• CLINICAL_TRIALS research · 2026-03-12
  Clinical Trial Update: Dalpiciclib Combined With Endocrine Therapy and Metronomic Capecitabine vs Dalpiciclib Combined With Endocrine Therapy for First-line Treatment [Phase 3]

  Phase 3 trial assessing dalpiciclib plus endocrine therapy with or without metronomic capecitabine as first-line treatment for breast cancer…

• CLINICAL_TRIALS research · 2026-03-12
  Clinical Trial Update: Study of Multi-mode Thermal Therapy Combined With Immunotherapy In Patients With HER2-negative Breast Cancer With Liver Metastases [Phase 2]

  Phase 2 clinical trial evaluating multi-mode thermal therapy in combination with immunotherapy for HER2-negative breast cancer with liver me…

• CLINICAL_TRIALS research · 2026-03-12
  Clinical Trial Update: Safety and Pharmacokinetics of Tucatinib (MK-7119) in Chinese Participants With Cancer (MK-7119-002) [Phase 1]

  Phase 1 clinical trial MK-7119-002 assesses safety and pharmacokinetics of tucatinib (MK-7119) in Chinese participants with cancer; the stud…

• CLINICAL_TRIALS research · 2026-03-12
  Clinical Trial Update: Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors [Phase 1, Phase 2]

  A Mayo Clinic-sponsored phase 1/2 trial evaluating a personalized neoantigen peptide-based vaccine in combination with pembrolizumab for adv…

• CLINICAL_TRIALS research · 2026-03-12
  Clinical Trial Update: SAHARA-04 : Adaptive Radiotherapy in Hypersensitive Patients and High Locoregional Risk Breast Cancer With ETHOS Technology [NA]

  SAHARA-04 is a trial evaluating adaptive radiotherapy using ETHOS technology for hypersensitive patients with high locoregional risk breast …

• CLINICAL_TRIALS research · 2026-03-12
  Clinical Trial Update: Personalization of Breast Radiotherapy According to Loco-regional Recurrence Risk and Toxicity Probability [NA]

  A recruiting clinical trial investigating personalization of breast radiotherapy based on loco-regional recurrence risk and predicted toxici…

• CLINICAL_TRIALS research · 2026-03-12
  Clinical Trial Update: A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors [Phase 1]

  Phase 1 study evaluating NKT5097 in adults with advanced or metastatic solid tumors, including various breast cancer subtypes and gynecologi…

• CLINICAL_TRIALS research · 2026-03-12
  Clinical Trial Update: A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer [Phase 2]

  A Phase 2 neoadjuvant study to evaluate Zanidatamab in combination with chemotherapy for HER2-positive breast cancer is currently recruiting…